CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY – Get Free Report) saw a significant drop in short interest in June. As of June 15th, there was short interest totaling 16,077 shares, a drop of 75.9% from the May 31st total of 66,704 shares. Currently, 0.0% of the shares of the stock are sold short. Based on an average daily trading volume, of 219,950 shares, the short-interest ratio is currently 0.1 days.
Wall Street Analysts Forecast Growth
Several research analysts have recently commented on the company. UBS Group downgraded CochLear from a “strong-buy” rating to a “hold” rating in a report on Thursday, April 23rd. Zacks Research upgraded CochLear from a “strong sell” rating to a “hold” rating in a report on Monday, June 22nd. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, CochLear has a consensus rating of “Moderate Buy”.
Read Our Latest Research Report on CHEOY
CochLear Price Performance
CochLear Company Profile
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Recommended Stories
- Five stocks we like better than CochLear
- 3 ETFs Pairing Market-Beating Returns With High Dividend Yields
- MarketBeat Week in Review – 06/22 – 06/26
- Rocket Lab’s NASA Win Tests Key Support After Sharp Pullback
- AST SpaceMobile Just Nailed a Major Launch—So Why Is the Stock Crashing?
Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.
